Imprime PGG improves the efficacy of carboplatin, paclitaxel, and cetuximab chemoimmunotherapy of advanced non-small cell lung cancer (NSCLC).

被引:0
|
作者
Thomas, Michael [1 ]
Sadjadian, Parvis [2 ]
Kollmeier, Jens [3 ]
Hao, Zhonglin [4 ]
Patchen, Myra [5 ]
Lowe, Jamie [5 ]
Mattson, Paulette [5 ]
Huhn, Richard D. [5 ]
Bose, Nandita [5 ]
Antonysamy, Mary [5 ]
Gargano, Michele [5 ]
Gordon, Keith [5 ]
Schneller, Folker [6 ]
机构
[1] Univ Clin Heidelberg, Heidelberg, Germany
[2] Johannes Wesling Klinikum Minden, Minden, Germany
[3] Helios Clin Emil von Behring, Berlin, Germany
[4] Georgia Hlth Sci Univ, Augusta, GA USA
[5] Biothera Inc, Eagan, MN USA
[6] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
关键词
D O I
10.1158/1078-0432.14AACRIASLC-A26
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A26
引用
收藏
页数:1
相关论文
共 50 条
  • [1] PGG β-GLUCAN WITH CARBOPLATIN, PACLITAXEL AND CETUXIMAB FOR CHEMOIMMUNOTHERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Schneller, F.
    Thomas, M.
    Sadjadian, P.
    Kollmeier, J.
    Bose, N.
    Antonysamy, M.
    Patchen, M.
    Lowe, J.
    Huhn, R. D.
    Mattson, P.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S40 - S41
  • [2] Tolerability and activity of weekly paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC)
    Fabi, A
    De Marco, S
    Barduagni, M
    Gamucci, T
    Cortesi, E
    De Marinis, F
    Ferraresi, V
    Saltarelli, R
    Gabriele, A
    Accettura, C
    Cognetti, F
    ANNALS OF ONCOLOGY, 2000, 11 : 4 - 4
  • [3] Concurrent chemoradiotherapy with paclitaxel and carboplatin for locoregionally advanced non-small cell lung cancer (NSCLC)
    Kaplanova, J.
    Tomiskova, M.
    Babickova, L.
    Kadlec, B.
    Slampa, P.
    Skrickova, J.
    LUNG CANCER, 2006, 52 : S34 - S34
  • [4] Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
    Sgambato, Assunta
    Casaluce, Francesca
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 578 - 580
  • [5] Review of paclitaxel/carboplatin in advanced non-small cell lung cancer
    Bonomi, P
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 55 - 59
  • [6] Carboplatin and Weekly Paclitaxel for the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) During Pregnancy
    Azim, Hatem A., Jr.
    Scarfone, Giovanna
    Peccatori, Fedro A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 559 - 560
  • [7] Safety and efficacy of AMG 655 in combination with paclitaxel and carboplatin (PC) in patients with advanced non-small cell lung cancer (NSCLC)
    Paz-Ares, L.
    Sanchez Torres, J. M.
    Diaz-Padilla, I.
    Links, M.
    Reguart, N.
    Boyer, M.
    Wiezorek, J.
    Sabin, T.
    Pan, Y.
    Van Meerbeeck, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Carboplatin and paclitaxel (Taxol®) for non-small cell lung cancer [NSCLC], a standard regimen?
    Pralong-Kohler, J
    Stupp, R
    Monnerat, C
    Bauer, J
    Stalder, M
    Perey, L
    Leyvraz, S
    ANNALS OF ONCOLOGY, 1998, 9 : 87 - 87
  • [9] Paclitaxel Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Kanat, Ozkan
    Cubukcu, Erdem
    Cubukcu, Sinem
    Aksoy, Savas
    Canhoroz, Mustafa
    Karadag, Oya
    Alkis, Nihan
    Manavolglu, Osman
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 293 - 295
  • [10] Paclitaxel and Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Sadic, Murat
    Alavi, Abass
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7